ALMS
Alumis Inc
NASDAQ · Pharmaceuticals
$26.19
-0.15 (-0.57%)
Performance
1D
—
1W
-0.87%
1M
+24.18%
3M
+394.15%
6M
+492.53%
1Y
+443.36%
YTD
+192.46%
Open$26.97
Previous Close$26.34
Day High$27.78
Day Low$26.08
52W High$28.29
52W Low$2.76
Volume1.46M
Avg Volume1.55M
Market Cap3.27B
P/E Ratio—
EPS$-3.85
SectorPharmaceuticals
Volume Analysis
0.95x average volume
Technical Indicators
SMA 50
$16.50
Above
SMA 200
$7.35
Above
RSI (14)
57.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-6.4% upside
Current
$26.19
$26.19
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 878.33M | 917.39M | 923.52M |
| Net Income | 120.27M | 166.79M | 141.53M |
| Profit Margin | 13.7% | 18.2% | 15.3% |
| EBITDA | 272.46M | 241.94M | 249.41M |
| Free Cash Flow | 126.96M | 147.40M | 173.90M |
| Rev Growth | +6.0% | +16.1% | -7.6% |
| Debt/Equity | 0.25 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |